Skin Cancer

>

Latest News

melanoma/skin
10-Year Data Support Pembrolizumab as Standard for Advanced Melanoma

September 21st 2024

Pembrolizumab led to improved survival over ipilimumab in patients with unresectable advanced melanoma, according to long-term data.

Two Phase 3 Trials of Pembrolizumab in NSCLC, CSCC to Be Discontinued By Merck
Two Phase 3 Trials of Pembrolizumab in NSCLC, CSCC to Be Discontinued By Merck

September 8th 2024

Close up illustration of skin.
Oncolytic Peptide VP-315 Reduces Tumor Size in Patients With Basal Cell Carcinoma

August 31st 2024

Illustration close up of carcinoma.
DART Releases New Guidelines on Radiation-Based Treatments for Basal Cell, Squamous Cell Carcinoma

August 29th 2024

Illustration close up of skin
Higher Corticosteroid Peak Dose May Worsen Survival in Patients With Treatment-Related Adverse Events

August 28th 2024

Video Interviews
Podcasts
The Vitals Podcast
the vitals
Oncology Nursing News
Key Advances in Cancer Survivorship Toxicity Management
Latest CME Events & Activities

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Annual Hematology Meeting: Preceding the 66th ASH Annual Meeting and Exposition

December 6, 2024

Register Now!

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?

View More

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Register Now!

Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

More News

© 2024 MJH Life Sciences

All rights reserved.